Diagnosis of allergic reactions to sulfonamides

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 54, Issue 58, 1999, Pages 28-32

  Gruchalla, Rebecca S ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SULFONAMIDE;

ALLERGIC REACTION; ANTIBODY PRODUCTION; CONFERENCE PAPER; DRUG EFFECT; DRUG HYPERSENSITIVITY; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; LYMPHOCYTE TRANSFORMATION; LYMPHOCYTOTOXICITY; PRIORITY JOURNAL; SKIN TEST;

EID: 0033491134     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1999.tb04745.x     Document Type: Conference Paper

References (36)

1. Lazarou J, Pomeranz B, Corey P. Incidence of adverse drug reactions in hospitalized patients - a meta-analysis of prospective studies. JAMA 1998;279:1200-1205.
2. Carr A, Swanson C, Penny R, Cooper D. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with pneumocystis Carinii pneumonia and AIDS. J Infect Dis 1993;167:180-185.
3. Hennessy S, Strom B, Berlin J. Predicting cutaneous hypersensitivity reactions to cotrimoxazole in HIV-infected individuals receiving primary Pneumocystis carinii pneumonia prophylaxis. J Gen Intern Med 1995;140:380-386.
4. Roujeau J, Stern R. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;19:1271-1285.
5. Lancôt K, Ghajar B, Shear N, Naranjo C. Improving the diagnosis of hypersensitivity reactions associated with sulfonamides. J Clin Pharmacol 1994;34:1228-1233.
6. Gordin F, Simon G, Wofsy C, Mills J. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1984;100:495-499.
7. Coopman S, Johnson R, Platt R, Stern R. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993;328:1670-1674.
8. Arnold P, Guglielmo B, Hollander H. Severe hypersensitivity reaction upon rechallenge with trimethoxazole-sulfamethoxazole in a patient with AIDS. Drug Intel Clin Pharm 1988;22:43-45.
9. Bayard P, Berger T, Jacobson M. Drug hypersensitivity reactions and human immunodeficiency virus disease. J Acquir Immune Defic Syndr 1992;5:1237-1257.
10. Lee B, Safrin S. Interactions and toxicities of drugs used in patients with AIDS. Clin Infect Dis 1992;14:773-779.
11. Greenberger P, Patterson R. Management of drug allergy in patients with acquired immunodeficiency syndrome. J Allergy Clin Immunol 1987;79:484-488.
12. Shear N, Spielberg S. An in vitro lymphocytotoxicity assay for studying adverse reactions to sulfonamides. Br J Dermatol 1985;28:S112-S113.
13. Rieder M, Uetrecht J, Shear N, Spielberg S. Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides. J Pharmacol Exp Ther 1988;244:724-728.
14. Rieder M, Shear N, Kanee A, Tang B, Spielberg S. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharmacol Ther 1991;49:13-17.
15. Carr A, Tindall B, Penny R, Cooper D. In vitro cytoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV. Clin Exp Immunol 1993;94:21-25.
16. Meekens C, Sullivan T, Gruchalla R. Immunochemical analysis of sulfonamide drug allergy: identification of sulfamethoxazole-substituted human serum proteins. J Allergy Clin Immunol 1994;94:1017-1024.
17. Koopmans P, van der Ven A, Vree T, van der Meer J. Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic? AIDS 1995;9: 217-212.
18. Gruchalla R, Pesenko RD, Do TT, Skiest DJ. Sulfonamide-induced reactions in patients with AIDS - role of covalent protein haptenation. J Allergy Clin Immunol 1998;101:371-378.
19. Rieder M, Uetrecht J, Shear N, Cannon M, Miller M, Spielberg S. Diagnosis of sulfonamide hypersensitivity reactions by in vitro rechallenge with hydroxylamine metabolites of sulfonamides. Ann Intern Med 1989;110:286-289.
20. Cribb A, Speilberg S. Hepatic microsomal metabolism of sulfamethoxazole to hydroxylamine. Drug Metab Dispos 1990;18:784-787.
21. Litt J, Pawlak WA Jr. Drug eruption reference manual. In: Litt J, Pawlak WA Jr, editors. Cleveland: Wal-Zac Enterprises, 1995.
22. Gruchalla R, Sullivan T. Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazole poly-L-tyrosine. J Allergy Clin 1991;88:784-792.
23. Kalish R, LaPorte A, Wood J, Johnson K. Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions. J Allergy Clin Immunol 1994;94:465-472.
24. + T cells in individuals allergic to sulfonamides, phenytoin and carbamazepine. J Immunol 1995;155:462-472.
25. Nyfeler B, Pichler W. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997;27:175-181.
26. Cribb A, Miller M, Leeder J, Hill J, Spielberg S. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Drug Metab Dispos 1991;19:900-906.
27. Spielberg S. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. Fed Proc 1984;43:2308-2313.
28. Shear N, Spielberg S. In vitro evaluation of a toxic metabolite of sulfadiazine. Can J Physiol Pharmacol 1985;63:1370-1372.
29. Shear N, Speilberg S, Grant D, Tang B, Kalow W. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 1986;105:179-184.
30. Pirmohamed M, Coleman M, Hussain F, Breckenridge A, Park B. Direct and metabolism-dependent toxicity of sulfasalazine and its principal metabolites towards human erythrocytes and leucocytes. Ann Intern Med 1985;63:1370-1372.
31. Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau J, Bagot M. Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol 1995;131:544-551.
32. Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau J-C, Bagot M. Metabolic predisposition to cutaneous drug reactions: role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol 1995;131:544-551.
33. Pumford N, Martin B, Thomassen D, et al. Serum antibodies from halothane hepatitis patients react with the rat endoplasmic reticulum protein Erp72. Chem Res Toxicol 1993;6:609-615.
34. Leeder J, Riley R, Cook V, Spielberg S. Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions. J Pharmacol Exp Ther 1992;263:360-367.
35. Cribb A, Pohl L, Spielberg S, Leeder J. Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum luminal proteins. J Pharmacol Exp Ther 1997;282:1064-1072.
36. Cribb A, Nuss C, Alberts D, et al. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection. Chem Res Toxicol 1996;9:500-507.